Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways. (1st October 2019) - Reich, K.; Reich, J.L.K.; Falk, T.M.; Blödorn‐Schlicht, N.; Mrowietz, U.; von Kiedrowski, R.; Pfeiffer, C.; Niesmann, J.; Frambach, Y.; Warren, R.B.